Clinical trial
Can Fecal Microbiota Alterations Predict a Refractory Disease Course to Standard Steroid Therapy in Patients With Active Ulcerative Colitis?
NCT03460847 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Can Fecal Microbiota Alterations Predict a Refractory Disease Course to Standard Steroid Therapy in Patients With Active Ulcerative Colitis?
- Lead sponsor
- Medical University of Graz
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2018
- Completion date
- March 1, 2021
- Enrollment
- 114 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.